Prophylactic Proton Pump Inhibition for Esophageal Protection in Lung Radiation Therapy
Conditions
- Primary Lung Cancer
- Non Small Cell Lung Cancer
- Small Cell Lung Cancer
Interventions
- DRUG: Experimental (Health Canada Approved Proton Pump Inhibitors)
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's